Bausch & Lomb (BLCO) director awarded 15,842 RSUs under 2022 Omnibus Incentive Plan

Rhea-AI Filing Summary

VON ESCHENBACH ANDREW C. reported acquisition or exercise transactions in this Form 4 filing.

Bausch & Lomb Corp director Andrew C. Von Eschenbach received an annual equity grant of 15,842 common shares, reported as a grant or award at $15.78 per share. The award reflects restricted share units granted under the company’s 2022 Omnibus Incentive Plan and is scheduled to vest before the next annual shareholder meeting, bringing his direct holdings to 86,656 common shares.

Insights

Equity compensation analyst

Routine RSU grant increases director’s equity stake modestly.

The filing shows a non-employee director of Bausch & Lomb Corp receiving 15,842 restricted share units as part of the company’s 2022 Omnibus Incentive Plan. This is standard board compensation, not an open-market purchase or sale.

The RSUs vest immediately before the next annual shareholder meeting, aligning the director’s incentives with near-term company performance. After this grant, his direct holdings total 86,656 common shares, indicating a moderate personal stake with no remaining derivative positions disclosed in this filing.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider VON ESCHENBACH ANDREW C.

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Shares, No Par Value	15,842	$15.78	$250K

Holdings After Transaction: Common Shares, No Par Value — 86,656 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSU grant size: 15,842 shares Grant reference price: $15.78 per share Post-grant holdings: 86,656 shares +1 more

4 metrics

RSU grant size 15,842 shares Annual grant of restricted share units to non-employee director

Grant reference price $15.78 per share Reported price for RSU grant on common shares

Post-grant holdings 86,656 shares Total common shares directly held after the award

Transaction code A (grant, award, or other acquisition) Non-derivative acquisition reported on Form 4

Key Terms

restricted share units ("RSUs"), Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, non-employee directors, annual meeting of shareholders

4 terms

restricted share units ("RSUs") financial

"Reflects the annual grant of restricted share units ("RSUs") to non-employee directors"

Bausch + Lomb Corporation 2022 Omnibus Incentive Plan financial

"under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated"

non-employee directors regulatory

"Reflects the annual grant of restricted share units ("RSUs") to non-employee directors"

Non-employee directors are board members who do not work for the company as salaried employees and usually do not hold day-to-day management roles. They act like outside referees or independent coaches, providing oversight, asking tough questions, and protecting shareholders’ interests; investors care because these directors help ensure management is accountable, reduce conflicts of interest, and influence decisions that affect company strategy and long-term value.

annual meeting of shareholders regulatory

"scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders"

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

VON ESCHENBACH ANDREW C.

(Last) (First) (Middle)

C/O BAUSCH + LOMB CORPORATION

520 APPLEWOOD CRESCENT

(Street)

VAUGHAN L4K 4B4

(City) (State) (Zip)

ONTARIO, CANADA

(Country)

2. Issuer Name and Ticker or Trading Symbol
Bausch & Lomb Corp [ BLCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares, No Par Value	05/26/2026		A		15,842(1)	A	$15.78	86,656	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders.

	/s/ Debra E. Levin, attorney-in-fact	05/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Bausch & Lomb (BLCO) director Andrew C. Von Eschenbach report on this Form 4?

He reported receiving 15,842 restricted share units in Bausch & Lomb common shares as a grant or award. This equity grant is part of his compensation as a non-employee director and increases his direct holdings to 86,656 common shares after the transaction.

Was the Bausch & Lomb (BLCO) Form 4 transaction a market purchase or sale?

No, the transaction was a grant or award coded “A,” not a market trade. The director acquired 15,842 restricted share units as compensation under the 2022 Omnibus Incentive Plan, rather than buying or selling shares in the open market.

How many Bausch & Lomb (BLCO) shares does the director hold after this Form 4 transaction?

After the grant, Andrew C. Von Eschenbach directly holds 86,656 Bausch & Lomb common shares. This total includes the 15,842 restricted share units awarded in the filing, which will convert into common shares when they vest under the plan’s terms.

At what price was the Bausch & Lomb (BLCO) director equity grant reported?

The grant was reported at a value of $15.78 per common share for 15,842 shares. This figure reflects the award’s reference price for reporting purposes and does not represent an open-market purchase price set by the director.

When do the Bausch & Lomb (BLCO) restricted share units granted to the director vest?

The restricted share units are scheduled to vest immediately before the conclusion of the next annual meeting of shareholders. Once vested, they are settled in Bausch & Lomb common shares, aligning the director’s compensation with shareholder outcomes over that period.

What plan governs the Bausch & Lomb (BLCO) director’s restricted share unit grant?

The award was made under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. This plan provides equity-based compensation, including restricted share units, to non-employee directors and other eligible participants to align their interests with shareholders.